Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole safety and trough concentration in hematological malignancies
ChiCTR2100043331Phase 4Recruiting
- Sponsor
- Southern Medical University Shenzhen Hospital
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of voriconazole in invasive mycoses, sponsored by Southern Medical University Shenzhen Hospital. Primary endpoint: Voriconazole plasma concentration. Started Mar 2021; status: recruiting.
02
Drugs
voriconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on ChiCTR2100043331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043331.